Analysis Supports Role of Lotilaner Ophthalmic Solution for Demodex Blepharitis
In a systematic review and meta-analysis of available data, lotilaner ophthalmic solutions outperformed placebo, with few side effects, in treating Demodex blepharitis.
Stay updated with breaking news from Haris Ali. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a systematic review and meta-analysis of available data, lotilaner ophthalmic solutions outperformed placebo, with few side effects, in treating Demodex blepharitis.
Myelofibrosis affects about 25,000 people in the United States.
The FDA has just approved a drug that helps patients with anemia, a devastating side effect of one troublesome form of cancer
Around 134 cyclists from across the country participated in races held over span of three days
Symptom improvements have been hailed as ‘very compelling’ after results from a phase 1 study into a combination of drugs to treat myelofibrosis prove positive.